BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9826336)

  • 1. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue.
    Ward PN; Miles AJ; Sumner IG; Thomas LH; Lax AJ
    Infect Immun; 1998 Dec; 66(12):5636-42. PubMed ID: 9826336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.
    Wilson BA; Aminova LR; Ponferrada VG; Ho M
    Infect Immun; 2000 Aug; 68(8):4531-8. PubMed ID: 10899852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of a C-terminal fragment of Pasteurella multocida toxin.
    Busch C; Orth J; Djouder N; Aktories K
    Infect Immun; 2001 Jun; 69(6):3628-34. PubMed ID: 11349023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Pasteurella multocida toxin with vimentin.
    Shime H; Ohnishi T; Nagao K; Oka K; Takao T; Horiguchi Y
    Infect Immun; 2002 Nov; 70(11):6460-3. PubMed ID: 12379728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane interaction of Pasteurella multocida toxin involves sphingomyelin.
    Brothers MC; Ho M; Maharjan R; Clemons NC; Bannai Y; Waites MA; Faulkner MJ; Kuhlenschmidt TB; Kuhlenschmidt MS; Blanke SR; Rienstra CM; Wilson BA
    FEBS J; 2011 Dec; 278(23):4633-48. PubMed ID: 21951695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YopT domain of the PfhB2 toxin from Pasteurella multocida: protein expression, characterization, crystallization and crystallographic analysis.
    Kumar S; Hedrick V; Mattoo S
    Acta Crystallogr F Struct Biol Commun; 2018 Mar; 74(Pt 3):128-134. PubMed ID: 29497015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Backbone and side-chain resonance assignments of the membrane localization domain from Pasteurella multocida toxin.
    Brothers MC; Geissler B; Hisao GS; Satchell KJ; Wilson BA; Rienstra CM
    Biomol NMR Assign; 2014 Apr; 8(1):221-4. PubMed ID: 23765284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL8 Knockout: A Key to Resisting
    Yuan J; Zhao Q; Li J; Wen Y; Wu R; Zhao S; Lang YF; Yan QG; Huang X; Du S; Cao SJ
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791369
    [No Abstract]   [Full Text] [Related]  

  • 9. In Vivo Targets of
    Banu A; Lax AJ; Grigoriadis AE
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Membrane Redistribution and Depletion of Gαq-Protein by Pasteurella multocida Toxin.
    Clemons NC; Luo S; Ho M; Wilson BA
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27490568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of Pasteurella multocida toxin on neuronal cells.
    Surguy SM; Duricki DA; Reilly JM; Lax AJ; Robbins J
    Neuropharmacology; 2014 Feb; 77():9-18. PubMed ID: 24055502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What a difference a Dalton makes: bacterial virulence factors modulate eukaryotic host cell signaling systems via deamidation.
    Washington EJ; Banfield MJ; Dangl JL
    Microbiol Mol Biol Rev; 2013 Sep; 77(3):527-39. PubMed ID: 24006474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pasteurella multocida toxin as a transporter of non-cell-permeating proteins.
    Bergmann S; Jehle D; Schwan C; Orth JH; Aktories K
    Infect Immun; 2013 Jul; 81(7):2459-67. PubMed ID: 23630953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.
    Orth JH; Fester I; Siegert P; Weise M; Lanner U; Kamitani S; Tachibana T; Wilson BA; Schlosser A; Horiguchi Y; Aktories K
    FASEB J; 2013 Feb; 27(2):832-42. PubMed ID: 23150526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin.
    Babb RC; Homer KA; Robbins J; Lax AJ
    PLoS One; 2012; 7(11):e47188. PubMed ID: 23144805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.
    Hildebrand D; Heeg K; Kubatzky KF
    Infect Immun; 2011 Jan; 79(1):220-8. PubMed ID: 20956572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the membrane-targeting C1 domain in Pasteurella multocida toxin.
    Kamitani S; Kitadokoro K; Miyazawa M; Toshima H; Fukui A; Abe H; Miyake M; Horiguchi Y
    J Biol Chem; 2010 Aug; 285(33):25467-75. PubMed ID: 20534589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
    Seo J; Pyo H; Lee S; Lee J; Kim T
    Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation.
    Orth JH; Preuss I; Fester I; Schlosser A; Wilson BA; Aktories K
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7179-84. PubMed ID: 19369209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histidine Residues at the Active Site of the Pasteurella multocida Toxin.
    Pullinger GD; Lax AJ
    Open Biochem J; 2007; 1():7-11. PubMed ID: 18949067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.